By Josh White
Date: Monday 27 Oct 2025
(Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.
The AIM-traded company said profit before tax fell 5% to £10.1m for the year ended 30 June, while revenue declined 4% to £13.1m.
 or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
				
				 
			
You are here: news